AskBorsa

Speed Medical results, Q4 2021

Net profit, assets, equity and cash flow for Q4 2021, against the same period a year earlier, from the published financial statements.

Net profit11.42 millionEGP
Total assets783 millionEGP
Shareholders' equity458 millionEGP
Operating cash flow10.09 millionEGP

In short

  • Speed Medical's net profit for Q4 2021 was about 11.42 million EGP.
  • Total assets at the end of Q4 2021 were about 783 million EGP, and shareholders' equity about 458 million EGP.
  • Operating cash flow for Q4 2021 was positive at 10.09 million EGP.
Source: the Q4 2021 financial statements

Key lines against the same period a year earlier

This periodYear earlierChange
Net profit11.42 million——
Gross profit35.01 million——
Total assets783 million——
Total liabilities325 million——
Shareholders' equity458 million——
Total liabilities and equity783 million——
Operating cash flow10.09 million——
Investing cash flow-186 million——
Financing cash flow53.11 million——
Net change in cash-123 million——

Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.

The report file for this period has not been published yet.All of Speed Medical's statements, five yearsAsk the AI analyst about SPMD

Speed Medical's Q2 2026 results, the day they are published

One email on the day, no account, and a one-click stop in the email itself.

orFollow on TelegramEvery result as it lands, in the @askborsa channel

By subscribing you agree to receive these alerts only. Privacy policy

Other periods for Speed Medical